CELL SIGNALING TECHNOLOGY search Cell Signaling Technology CCNE1 products
includes other brands or spellings
|
| wb | | New England Biolabs polyclonal anti-cyclin E antibody was used in western blot to study that disialoganglioside (GD3) synthase gene expression suppresses vascular smooth muscle cell responses via the inhibition of ERK1/2 phosphorylation, cell cycle progression, and matrix metalloproteinase-9 expression. |
| wb | | Cell Signaling Technology mouse monoclonal cyclin E (HE12) antibody was used in western blot to study retinoblastoma phosphorylation in neuronal cell death. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology CCNE1 products
includes other brands or spellings
|
| ic | | Santa Cruz Biotechnology anti-cyclin E antibody was used in immunocytochemistry to detect the localozation of cyclin E in A92L cells transfected with HA-tagged NS1 and blocked infected A92L cells after entry into S phase. |
| ih | | Santa Cruz Biotechnologies anti-cyclin E antibody M-20 was used in immunohistochemistry to study the effect of expression of nuclear cdk2 and cdk4 in neurons on reactivation of herpes simplex virus. |
| ip, wb | | Santa Cruz Biotechnology rabbit anti-cyclin E (C-19, sc-198) antibody was used in western blot and immunoprecipitation to study cyclin A expression and retinoblastoma hyperphosphorylation. |
| ip, wb | | Santa Cruz Biotechnology cyclin E -M20 antibody was used in western blot and immunoprecipitation to study the effect of Epstein-Barr virus lytic replication on ATM checkpoint signal transduction. |
| ip, wb | | Santa Cruz Biotechnology anti-cyclin E antibody was used in HEK293F cells and in immunoprecipitation, western blot to study the role of association of TSG101 with p21Cip1/WAF1 in regulating of cell growth and differentiation. |
| ip, wb | | Santa Cruz Biotechnology anti-cyclin E antibodies HE12 and C-19 were used in human cells, and which were respectively used in western blot and immunoprecipitation, to study the effects of SF/HGF, c-myc, p27, Cdk2, or E2F1 on glioblastoma cell cycle progression. |
| ip, wb | | SCBT cyclin E (HE-12) antibody was used in western blot and immunoprecipitation to investigate the regulatoin of Fbw7-mediated cyclin E proteolysis by Ras. |
| ip, wb | | SCBT anti-cyclin E (HE12) antibody was used in western blot and anti-cyclin E (HE111) was used in immunoprecipitation to investigate the role of ORC2 in CDK2 activation. |
| ip, wb | | Santa Cruz Biotechnology antibody against cyclin E was used in western blot and immunoprecipitation to study the role of human aldehyde dehydrogenase 3A1 (ALDH3A1) to inhibit proliferation and promote survival of human corneal Epithelial Cells. |
| ip | | Santa Cruz Biotechnology anti-cyclin E antibody (C-19) was used in MCF-7S human breast cancer cells and in immunoprecipitation to study the mechanism by which IGF-I induces the activation of the cyclin D1-CDK4 complex. |
| wb | | Santa Cruz Biotechnology monoclonal anti-Cyclin E antibody was used in western blot to study HFz6 represses the canonical Wnt pathway by transmitting an antagonistic signaling cascade. |
| wb | | Santa Cruz anti-cyclin E antibody was used in western blot to identify the BCL6 as an inhibitor of anti-proliferative p19ARF-p53 signaling by a senescence rescue screen. |
| wb | | Santa Cruz Biotechnology antibody against cyclin E (M20) was used in western blot to identify cyclin E as a target of WT1 transcriptional repression. |
| wb | | Santa Cruz Biotechnologies monoclonal anti-cyclin E antibody was used in western blot to study the subnuclear distribution of the overexpressed human origin recognition complex (Orc1p) during the cell cycle. |
| wb | | Santa Cruz Biotechnology anti-Cyclin E antibody was used in HCT116，IMR90 and U2OS cells and in western blot to study the apoptotic transcriptional network affected by HDAC inhibitor suberoylanilide hydroxamic acid (SAHA) in cancer cells with inducible E2F1. |
| wb | | Santa Cruz Biotechnology antibody to cyclin E was used in western blot to examine cyclin E levels in human HT29 colon carcinoma sublines U9, HP1, HD3 and HD4. |
| wb | | Santa Cruz Biotechnology anti-cyclin E monoclonal antibody was used in western blot to detect cyclin E in human SAOS-2 cells. |
| wb | | SCBT anti-cyclin E (HE12) antibody was used in western blot to investigate the regulation of Cdc6 protein stability by p53. |
| wb | | Santa Cruz Biotechnology antibody against cyclin E was used in western blot to study the RB activation defect in tumor cell lines. |
BD BIOSCIENCES search BD Biosciences CCNE1 products
includes other brands or spellings
|
| ih | | Pharmingen CCNE1 antibody was tested in immunohistochemistry by HPA (CAB000308) . |
| ih | | PharMingen mouse monoclonal anti-cyclin E antibody was used in immunohistochemistry to study GnT-V expression in non-small cell lung cancers. |
| ip, wb | | BD polyclonal phospho-T62 cyclin E antibody was used in western blot and immunoprecipitation to investigate the regulatoin of Fbw7-mediated cyclin E proteolysis by Ras. |
| wb | | PharMingen anti-cyclin E antibody was used in western blot to study the requirement of galectin-3 phosphorylation for its anti-apoptotic function and cell cycle Aarrest. |
| wb | | PharMingen anti-cyclin E antibody was used in western blot to detect cyclin E in U937 cells incubated for 24 h with 1-mM SB or 2-µM SAHA ± 100-ng/ml TRAIL in the absence or presence of the pan-caspase inhibitor BOC-D-fmk. |
| wb | | PharMingen anti-cyclin E antibody was used in western blot to study the production of interleukin 15 by human colon cancer cells associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. |
| wb | | BD Biosciences murine monoclonal anti-cyclin E antibody was used in western blot to study expression of p53, ErbB1, ErbB2, and Raf-1 in lung cancer. |
MILLIPORE search Millipore CCNE1 products
includes other brands or spellings
|
| wb | | Upstate cyclin E monoclonal antibody was used in western blot to study the expression of CDK2-NLS immunocomplexes in transfected IIC9 cells. |
| wb | | Upstate Biotechnologies anti-cyclin E antibody was used in western blot to study COLO-357 cell growth inhibition by TGF beta1. |
THERMO FISHER SCIENTIFIC search Thermo Fisher Scientific CCNE1 products
includes other brands or spellings
|
| ih | | Lab Vision anti-cyclin E primary antibody (clone CYE05) was used in immunohistochemistry to detect cyclin E expression in human pancreatic adenocarcinoma. |
| ip, wb | | Neomarkers anti-cyclin E antibody was used in western blot and immunoprecipitation to detect cyclin E in HEK293 cells were co-transfected with a FLAG-YA plasmid and a dominant negative mutant of cdc2 (cdc2D146N), cdk2 (cdk2D145N), or cdk4 (cdk4D158N). |
| wb | | Lab Vision Cyclin E (G1- & S-phase Cyclin) Ab-2 antibody was tested in western blot by Abminer. |
MAIXIN
|
| ih | | Maixin anti-human cyclin E protein mAb (13A3) was used in immunohistochemistry to investigate the expression of cyclin E in human pancreatic cancer. |
Articles Reviewed |
| 1. Tadashi Yoshii et al. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. 2002 |
| 2. Zhongfa Yan et al. Transforming growth factor beta 1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1. 2002 |
| 3. Philip J Young et al. Minute virus of mice NS1 interacts with the SMN protein, and they colocalize in novel nuclear bodies induced by parvovirus infection. 2002 |
| 4. Kevin A Walter et al. Scatter factor/hepatocyte growth factor stimulation of glioblastoma cell cycle progression through G(1) is c-Myc dependent and independent of p27 suppression, Cdk2 activation, or E2F1-dependent transcription. 2002 |
| 5. Avi Shvarts et al. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling. 2002 |
| 6. David M Loeb et al. Cyclin E is a target of WT1 transcriptional repression. 2002 |
| 7. Xiaodan Yu et al. Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228. 2002 |
| 8. Hyesun Oh et al. Negative regulation of cell growth and differentiation by TSG101 through association with p21(Cip1/WAF1). 2002 |
| 9. Luis M Schang et al. Explant-induced reactivation of herpes simplex virus occurs in neurons expressing nuclear cdk2 and cdk4. 2002 |
| 10. Nathan H Lents et al. Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2. 2002 |
| 11. Irene H L Hamelers et al. Insulin-like growth factor I triggers nuclear accumulation of cyclin D1 in MCF-7S breast cancer cells. 2002 |
| 12. Cristina Broceño et al. RB activation defect in tumor cell lines. 2002 |
| 13. Jeanho Yun et al. Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway. 2003 |
| 14. Eric S Calhoun et al. BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets. 2003 |
| 15. Hiroki Kuniyasu et al. Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. 2003 |
| 16. Wen Hong Shen et al. Tumor necrosis factor alpha inhibits cyclin A expression and retinoblastoma hyperphosphorylation triggered by insulin-like growth factor-I induction of new E2F-1 synthesis. 2004 |
| 17. Roberto R Rosato et al. Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells. 2003 |
| 18. Tamar Golan et al. The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade. 2004 |
| 19. Hirotoshi Dosaka-Akita et al. Expression of N-acetylglucosaminyltransferase v is associated with prognosis and histology in non-small cell lung cancers. 2004 |
| 20. Sung-Kwon Moon et al. Disialoganglioside (GD3) synthase gene expression suppresses vascular smooth muscle cell responses via the inhibition of ERK1/2 phosphorylation, cell cycle progression, and matrix metalloproteinase-9 expression. 2004 |
| 21. Maria Rosa Lidonnici et al. Subnuclear distribution of the largest subunit of the human origin recognition complex during the cell cycle. 2004 |
| 22. Ayumi Kudoh et al. Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. 2005 |
| 23. Malika Hamdane et al. p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death. 2005 |
| 24. Nichole Boyer Arnold et al. Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein. 2005 |
| 25. Aglaia Pappa et al. Human aldehyde dehydrogenase 3A1 inhibits proliferation and promotes survival of human corneal epithelial cells. 2005 |
| 26. Yuichi J Machida et al. Acute reduction of an origin recognition complex (ORC) subunit in human cells reveals a requirement of ORC for Cdk2 activation. 2005 |
| 27. Alex C Minella et al. Ras activity regulates cyclin E degradation by the Fbw7 pathway. 2005 |
| 28. Anja Duursma et al. p53-Dependent regulation of Cdc6 protein stability controls cellular proliferation. 2005 |
| 29. Hui Yue et al. Expression of cell cycle regulator p57kip2, cyclinE protein and proliferating cell nuclear antigen in human pancreatic cancer: an immunohistochemical study. 2005 |
| 30. Alrik P Los et al. The retinoblastoma family proteins bind to and activate diacylglycerol kinase zeta. 2006 |
| 31. Jing Tan et al. Apoptosis signal-regulating kinase 1 is a direct target of E2F1 and contributes to histone deacetylase inhibitor-induced apoptosis through positive feedback regulation of E2F1 apoptotic activity. 2006 |
| 32. Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |
| 33. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |